Skip to main navigation Skip to search Skip to main content

First-SIGNAL: First-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung

  • Ji Youn Han
  • , Keunchil Park
  • , Sang We Kim
  • , Dae Ho Lee
  • , Hyae Young Kim
  • , Heung Tae Kim
  • , Myung Ju Ahn
  • , Tak Yun
  • , Jin Seok Ahn
  • , Cheolwon Suh
  • , Jung Shin Lee
  • , Sung Jin Yoon
  • , Jong Hee Han
  • , Jae Won Lee
  • , Sook Jung Jo
  • , Jin Soo Lee*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'First-SIGNAL: First-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science